Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.86B |
| 2 |
Apple
AAPL
|
+$2.18B |
| 3 |
Microsoft
MSFT
|
+$1.47B |
| 4 |
Amazon
AMZN
|
+$943M |
| 5 |
Alibaba
BABA
|
+$864M |
Top Sells
| 1 |
Keurig Dr Pepper
KDP
|
+$187M |
| 2 |
BFT.U
Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an
BFT.U
|
+$178M |
| 3 |
NIO
NIO
|
+$156M |
| 4 |
Oracle
ORCL
|
+$151M |
| 5 |
PayPal
PYPL
|
+$148M |
Sector Composition
| 1 | Technology | 18.9% |
| 2 | Consumer Discretionary | 12.17% |
| 3 | Healthcare | 12.05% |
| 4 | Financials | 9.25% |
| 5 | Industrials | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Cardlytics
CDLX
$81.5M
| $2.94M | ﹤0.01% |
20,610
-53,039
| -72% | -$7.57M |
|
2202
Arthur J. Gallagher & Co
AJG
$74.7B
| $2.94M | ﹤0.01% |
23,733
-309,342
| -93% | -$38.3M |
|
2203
BiomX
PHGE
$12.9M
| $2.94M | ﹤0.01% |
46,005
+4,475
| +11% | +$285K |
|
|
AGTC
2204
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.93M | ﹤0.01% |
717,363
+100,935
| +16% | +$413K |
|
2205
iShares MSCI Sweden ETF
EWD
$320M
| $2.93M | ﹤0.01% |
73,653
+52,601
| +250% | +$2.09M |
|
2206
UWM Holdings
UWMC
$1.45B
| $2.92M | ﹤0.01% |
222,590
-2,149,208
| -91% | -$28.2M |
|
2207
The Ensign Group
ENSG
$9.48B
| $2.92M | ﹤0.01% |
40,060
+5,881
| +17% | +$429K |
|
2208
Evolent Health
EVH
$1B
| $2.92M | ﹤0.01% |
182,085
-584,208
| -76% | -$9.37M |
|
|
EGRX
2209
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.92M | ﹤0.01% |
62,596
+35,886
| +134% | +$1.67M |
|
2210
National Bank Holdings
NBHC
$1.43B
| $2.91M | ﹤0.01% |
88,801
+25,415
| +40% | +$833K |
|
2211
Relay Therapeutics
RLAY
$712M
| $2.9M | ﹤0.01% |
+69,695
| New | +$2.9M |
|
|
CGC
2212
Canopy Growth
CGC
$452M
| $2.89M | ﹤0.01% |
+11,747
| New | +$2.89M |
|
2213
Quince Therapeutics
QNCX
$87M
| $2.89M | ﹤0.01% |
+104,090
| New | +$2.89M |
|
|
BMTC
2214
DELISTED
Bryn Mawr Bank Corp
BMTC
| $2.89M | ﹤0.01% |
+94,492
| New | +$2.89M |
|
|
GPMT
2215
Granite Point Mortgage Trust
GPMT
$140M
| $2.89M | ﹤0.01% |
289,111
-18,888
| -6% | -$189K |
|
2216
Novartis
NVS
$238B
| $2.89M | ﹤0.01% |
30,559
-107,089
| -78% | -$10.1M |
|
2217
iShares MSCI China ETF
MCHI
$8.37B
| $2.88M | ﹤0.01% |
+35,593
| New | +$2.88M |
|
2218
Palantir
PLTR
$404B
| $2.88M | ﹤0.01% |
122,223
-880,958
| -88% | -$20.7M |
|
2219
iShares Russell Mid-Cap Growth ETF
IWP
$20.8B
| $2.88M | ﹤0.01% |
28,029
+10,907
| +64% | +$1.12M |
|
|
LUXAU
2220
DELISTED
Lux Health Tech Acquisition Corp. Units
LUXAU
| $2.88M | ﹤0.01% |
+250,002
| New | +$2.88M |
|
|
FGNA.U
2221
DELISTED
FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one
FGNA.U
| $2.87M | ﹤0.01% |
270,300
| – | – |
|
2222
National CineMedia
NCMI
$458M
| $2.87M | ﹤0.01% |
77,065
+46,009
| +148% | +$1.71M |
|
|
NXDT
2223
NexPoint Diversified Real Estate Trust
NXDT
$182M
| $2.86M | ﹤0.01% |
+271,596
| New | +$2.86M |
|
|
FLXN
2224
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $2.86M | ﹤0.01% |
247,581
+187,542
| +312% | +$2.16M |
|
|
VSPRU
2225
DELISTED
Vesper Healthcare Acquisition Corp. Unit
VSPRU
| $2.85M | ﹤0.01% |
235,405
-3,364,595
| -93% | -$40.8M |
|